148 – Regulatory Considerations for Digital Health (S10E13)

Review how regulators address digital health tools and data in the context of drug development. Dialogue on evolving guidelines and compliance challenges with real-world cases. Pull real world literature examples from your OPR&D sources where appropriate.

The goal of the talk is to try and stay up to date on what has been going on and what is the most relevant. You will know more now. This has been a short dive and all people on board were ready to dive!